caroline nguyen - Academia.edu (original) (raw)
Uploads
Papers by caroline nguyen
Neonatology, 2010
The prolonged survival of inflammatory neutrophils, which is associated with their delayed remova... more The prolonged survival of inflammatory neutrophils, which is associated with their delayed removal from tissues, is a critical component in the pathogenesis of chronic inflammatory and autoimmune disorders in adults [1-4] and neonates . The accumulation of tissue neutrophils, a hallmark of the early phase of chronic inflammation, can mediate injury through two related processes: (1) the recruitment and activation of additional neutrophils from the circulation, and (2) the delayed clearance of neutrophils with inflammatory or cytotoxic function . Neutrophils activated by an inflammatory milieu can produce cytokines and cytotoxic factors which can also enhance continued inflammation and promote lung injury . Neonatal leukocytes have also been shown to produce , a chemokine closely associated with the pathogenesis of chronic inflammatory disorders .
Autoimmunity Reviews, 2009
a b s t r a c t a r t i c l e i n f o
Metabolic Syndrome and Related Disorders, 2010
Psoriasis (PsO) is a common chronic T cell-mediated inflammatory disorder traditionally thought t... more Psoriasis (PsO) is a common chronic T cell-mediated inflammatory disorder traditionally thought to manifest in the skin and joints (psoriatic arthritis, PsA). Recently, it has been shown that these patients have an increased risk for myocardial infarction and this was greater with increasing severity of psoriasis. Patients with psoriasis have reported to have cardiometabolic disturbances including obesity, insulin resistance, and dyslipidemia. This constellation of risk factors, referred to as the metabolic syndrome, increases the risk for atherosclerotic cardiovascular disease (ASCVD) and type 2 diabetes mellitus. The aim of this study was to determine the prevalence of metabolic syndrome in PsA. In our study, we examined the records of 105 patients with PsA to determine the prevalence of metabolic syndrome in PsA. This was a retrospective analysis of the Sacramento Veterans Affairs database. Our results demonstrated an increased prevalence of the metabolic syndrome in patients with PsA (61/105 patients or 58.1%) compared to the 35.2 % reported for the Third National Health and Nutrition Examination Survery (NHANES III) data. Thus, patients with PsA have a very high prevalence of metabolic syndrome, which predisposes them to an increased risk of both diabetes and ASCVD.
Neonatology, 2010
The prolonged survival of inflammatory neutrophils, which is associated with their delayed remova... more The prolonged survival of inflammatory neutrophils, which is associated with their delayed removal from tissues, is a critical component in the pathogenesis of chronic inflammatory and autoimmune disorders in adults [1-4] and neonates . The accumulation of tissue neutrophils, a hallmark of the early phase of chronic inflammation, can mediate injury through two related processes: (1) the recruitment and activation of additional neutrophils from the circulation, and (2) the delayed clearance of neutrophils with inflammatory or cytotoxic function . Neutrophils activated by an inflammatory milieu can produce cytokines and cytotoxic factors which can also enhance continued inflammation and promote lung injury . Neonatal leukocytes have also been shown to produce , a chemokine closely associated with the pathogenesis of chronic inflammatory disorders .
Autoimmunity Reviews, 2009
a b s t r a c t a r t i c l e i n f o
Metabolic Syndrome and Related Disorders, 2010
Psoriasis (PsO) is a common chronic T cell-mediated inflammatory disorder traditionally thought t... more Psoriasis (PsO) is a common chronic T cell-mediated inflammatory disorder traditionally thought to manifest in the skin and joints (psoriatic arthritis, PsA). Recently, it has been shown that these patients have an increased risk for myocardial infarction and this was greater with increasing severity of psoriasis. Patients with psoriasis have reported to have cardiometabolic disturbances including obesity, insulin resistance, and dyslipidemia. This constellation of risk factors, referred to as the metabolic syndrome, increases the risk for atherosclerotic cardiovascular disease (ASCVD) and type 2 diabetes mellitus. The aim of this study was to determine the prevalence of metabolic syndrome in PsA. In our study, we examined the records of 105 patients with PsA to determine the prevalence of metabolic syndrome in PsA. This was a retrospective analysis of the Sacramento Veterans Affairs database. Our results demonstrated an increased prevalence of the metabolic syndrome in patients with PsA (61/105 patients or 58.1%) compared to the 35.2 % reported for the Third National Health and Nutrition Examination Survery (NHANES III) data. Thus, patients with PsA have a very high prevalence of metabolic syndrome, which predisposes them to an increased risk of both diabetes and ASCVD.